Coordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation

Nature Medicine

Volumn 15, Issue 3, 2009, Pages 259-266

  Ishii, Kiyo Aki ^a,j   Fumoto, Toshio ^a   Iwai, Kazuhiro ^b,c,d   Takeshita, Sunao ^a   Ito, Masako ^e   Shimohata, Nobuyuki ^c,k   Aburatani, Hiroyuki ^f   Taketani, Shigeru ^g   Lelliott, Christopher J ^h   Vidal Puig, Antonio ⁱ   Ikeda, Kyoji ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^h ASTRAZENECA R AND D   (Sweden)

ⁱ ADDENBROOKE S HOSPITAL   (United Kingdom)

^j UNIVERSITY OF TSUKUBA   (Japan)

^k NEXT21 ^*  (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN; IRON; IRON REGULATORY FACTOR; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PROTEIN; REACTIVE OXYGEN METABOLITE; PPARGC1A PROTEIN, MOUSE; PRIMER DNA; TFRC PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TRANSFERRIN RECEPTOR;

ARTICLE; BIOGENESIS; BONE MASS; BONE METABOLISM; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; ENERGY; ESTROGEN DEFICIENCY; GENE DELETION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IRON CHELATION; IRON TRANSPORT; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; DNA MICROARRAY; FEMALE; GENE SILENCING; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA PRIMERS; FEMALE; GENE KNOCKDOWN TECHNIQUES; IRON; MICE; MITOCHONDRIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOCLASTS; REACTIVE OXYGEN SPECIES; RECEPTORS, TRANSFERRIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 62049085382     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1910     Document Type: Article

References (39)

1. Karsenty, G. & Wagner, E.F. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406 (2002).
2. Teitelbaum, S.L. & Ross, F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649 (2003).
3. Zaidi, M. Skeletal remodeling in health and disease. Nat. Med. 13, 791-801 (2007).
4. Boyle, W.J., Simonet, W.S. & Lacey, D.L. Osteoclast differentiation and activation. Nature 423, 337-342 (2003).
5. Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292-304 (2007).
6. Sato, K. et al. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat. Med. 12, 1410-1416 (2006).
7. Brown, D. & Breton, S. Mitochondria-rich, proton-secreting epithelial cells. J. Exp. Biol. 199, 2345-2358 (1996).
8. Lin, J., Puigserver, P., Donovan, J., Tarr, P. & Spiegelman, B.M. Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem. 277, 1645-1648 (2002).
9. Lin, J., Handschin, C. & Spiegelman, B.M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1, 361-370 (2005).
10. St-Pierre, J. et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397-408 (2006).
11. Ahn, S. et al. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol. Cell. Biol. 18, 967-977 (1998).
12. Lelliott, C.J. et al. Ablation of PGC-1β results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol. 4, e369 (2006).
13. Dunn, L.L., Rahmanto, Y.S. & Richardson, D.R. Iron uptake and metabolism in the new millennium. Trends Cell Biol. 17, 93-100 (2007).
14. Andrews, N.C. Iron homeostasis: insights from genetics and animal models. Nat. Rev. Genet. 1, 208-217 (2000).
15. Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998).
16. Vianna, C.R. et al. Hypomorphic mutation of PGC-1β causes mitochondrial dysfunction and liver insulin resistance. Cell Metab. 4, 453-464 (2006).
17. Sonoda, J., Mehl, I.R., Chong, L.W., Nofsinger, R.R. & Evans, R.M. PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc. Natl. Acad. Sci. USA 104, 5223-5228 (2007).
18. Arany, Z. et al. The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35-46 (2007).
19. Lee, N.K. et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106, 852-859 (2005).
20. Garrett, I.R. et al. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85, 632-639 (1990).
21. Bax, B.E. et al. Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem. Biophys. Res. Commun. 183, 1153-1158 (1992).
22. Steinbeck, M.J., Appel, W.H. Jr., Verhoeven, A.J. & , Karnovsky M.J. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J. Cell Biol. 126, 765-772 (1994).
23. Lean, J.M. et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J. Clin. Invest. 112, 915-923 (2003).
24. Wan, Y., Chong, L.W. & Evans, R.M. PPAR-γ regulates osteoclastogenesis in mice. Nat. Med. 13, 1496-1503 (2007).
25. Koga, T. et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763 (2004).
26. Novack, D.V. et al. The IkB function of NF-κB2 p100 controls stimulated osteoclastogenesis. J. Exp. Med. 198, 771-781 (2003).
27. Borgna-Pignatti, C. Thalassemia. A few new tiles in a large mosaic. Haematologica 91, 1159-1161 (2006).
28. Voskaridou, E. & Terpos, E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br. J. Haematol. 127, 127-139 (2004).
29. Morabito, N. et al. Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. J. Bone Miner. Res. 19, 722-727 (2004).
30. Manolagas, S.C. & Jilka, R.L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332, 305-311 (1995).
31. Takeshita, S. et al. SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. 8, 943-949 (2002).
32. Ashizuka, M. et al. Novel translational control through an iron-responsive element by interaction of multifunctional protein YB-1 and IRP2. Mol. Cell. Biol. 22, 6375-6383 (2002).
33. Tokumitsu, H. et al. Mechanism of the generation of autonomous activity of Ca2+/ calmodulin-dependent protein kinase IV. J. Biol. Chem. 279, 40296-40302 (2004).
34. Takahashi, N. et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123, 2600-2602 (1988).
35. Takeshita, S. et al. c-Fms tyrosine 559 is a major mediator of M-CSF-induced proliferation of primary macrophages. J. Biol. Chem. 282, 18980-18990 (2007).
36. Allerson, C.R., Cazzola, M. & Rouault, T.A. Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome. J. Biol. Chem. 274, 26439-26447 (1999).
37. Sassa, S. & Kappas, A. Induction of aminolevulinate synthase and porphyrins in cultured liver cells maintained in chemically defined medium. Permissive effects of hormones on induction process. J. Biol. Chem. 252, 2428-2436 (1977).
38. Ito, M. et al. Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk. J. Bone Miner. Res. 20, 1828-1836 (2005).
39. Tatsumi, S. et al. Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab. 5, 464-475 (2007).